Why RADR Could Be Lantern Pharma's Most Undervalued Asset
Most people look at Lantern Pharma ($LTRN) and see a small biotech with a few oncology programs. What they often miss is RADR. RADR isn't a chatbot. It's an AI-driven oncology platform designed to identify which patients are most likely …